Description In vitro In vivo
ChemicalBook > CAS DataBase List > OMecaMtiv Mecarbil

OMecaMtiv Mecarbil

Description In vitro In vivo
Product Name
OMecaMtiv Mecarbil
CAS No.
873697-71-3
Chemical Name
OMecaMtiv Mecarbil
Synonyms
CS-827;CK1827452;CK-1827452;CK 1827452O;CK1827452, >98%;mecamtiv mecarbil;OMecaMtiv Mecarbil;Omecamtiv mecarbil?, >98%;OMecaMtiv Mecarbil USP/EP/BP;CK-1827452 (OMecaMtiv Mecarbil)
CBNumber
CB92561487
Molecular Formula
C20H24FN5O3
Formula Weight
401.43
MOL File
873697-71-3.mol
More
Less

OMecaMtiv Mecarbil Property

Melting point:
180℃
storage temp. 
-20°C Freezer
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
color 
White to Off-White
Water Solubility 
40.25mg/L at 25℃
LogP
-0.531
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H370Causes damage to organs

H372Causes damage to organs through prolonged or repeated exposure

Precautionary statements

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P307+P311IF exposed: call a POISON CENTER or doctor/physician.

P314Get medical advice/attention if you feel unwell.

P321Specific treatment (see … on this label).

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
21074
Product name
CK-1827452
Purity
≥98%
Packaging
1mg
Price
$37
Updated
2024/03/01
Cayman Chemical
Product number
21074
Product name
CK-1827452
Purity
≥98%
Packaging
5mg
Price
$169
Updated
2024/03/01
Cayman Chemical
Product number
21074
Product name
CK-1827452
Purity
≥98%
Packaging
10mg
Price
$301
Updated
2024/03/01
Cayman Chemical
Product number
21074
Product name
CK-1827452
Purity
≥98%
Packaging
25mg
Price
$661
Updated
2024/03/01
TRC
Product number
C544000
Product name
CK1827452
Packaging
50mg
Price
$820
Updated
2021/12/16
More
Less

OMecaMtiv Mecarbil Chemical Properties,Usage,Production

Description

Omecamtiv mecarbil (CK-1827452) is a specific cardiac myosin activator and a clinical drug for left ventricular systolic heart failure. Phase 2.

In vitro

In vitro, Omecamtiv mecarbil selectively activates cardiac myosin by increasing the myosin ATPase rate. In isolated cardiac myocytes, Omecamtiv mecarbil results in increase of myocyte contractility and overcomes of the myosin inhibitor BDM without increasing the calcium transient or inhibiting the PDE pathway. [

In vivo

Omecamtiv mecarbil significantly increases fractional shortening starting at 0.4 mM plasma concentrations in SD rats, sham animals and in rats with heart failure. In conscious dogs with myocardial infarction (MI-sHF), Omecamtiv mecarbil leads to a significant increase in wall thickening (25%), stroke volume (44%), cardiac output (22%) and left ventricular (LV) systolic ejection time (26%). In addition, Omecamtiv mecarbil also results in the decreases of some hemodynamic parameters including heart rate, mean left atrial pressure, and LV end-diastolic pressure. In conscious dogs with left ventricular hypertrophy (LVH-sHF), Omecamtiv mecarbil leads to similar and not statistically different effects on hemodynamic parameters.

Uses

CK 1827452 is a promising new drug in systolic heart failure. It accelerates the transition of myosin into the force-generating state without affecting cardiac myocyte calcium homeostasis. CK 1827452 increases cardiac function by increasing the duration of ejection without changing the rates of contraction.

Definition

ChEBI: Omecamtiv mecarbil is a member of ureas.

Biological Activity

omecamtiv mecarbil (ck-1827452) is the first potent cardiac myosin activator that can specifically activate the cardiac myosin s1 domain but not other muscle myosins. in

target

ATPase

References

1. malik fi1, hartman jj, elias ka, morgan bp, rodriguez h, brejc k, anderson rl, sueoka sh, lee kh, finer jt, sakowicz r, baliga r, cox dr, garard m,godinez g, kawas r, kraynack e, lenzi d, lu pp, muci a, niu c, qian x, pierce dw, pokrovskii m, suehiro i, sylvester s, tochimoto t, valdez c, wang w,katori t, kass da, shen yt, vatner sf, morgans dj. cardiac myosin activation: a potential therapeutic approach for systolic heart failure. science. 2011 mar 18;331(6023):1439-43.

OMecaMtiv Mecarbil Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

OMecaMtiv Mecarbil Suppliers

MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32161
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19553
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
Aceschem Inc.
Tel
+1-817863-6948 +1-(817)863-6948
Email
sales@aceschem.com
Country
United States
ProdList
19632
Advantage
58
United States Biological
Tel
--
Fax
--
Email
sales@advtechind.com
Country
United States
ProdList
6075
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
Axon Medchem LLC
Tel
--
Fax
--
Email
info@axonmedchem.com
Country
United States
ProdList
763
Advantage
58
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
NE Scientific
Tel
--
Fax
--
Country
United States
ProdList
5030
Advantage
55
More
Less

View Lastest Price from OMecaMtiv Mecarbil manufacturers

Shenzhen Excellent Biotech Co., Ltd.
Product
Omecamtiv Mecarbil 873697-71-3
Price
US $1.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
5000kg
Release date
2020-08-20
Career Henan Chemical Co
Product
OMecaMtiv Mecarbil 873697-71-3
Price
US $1.00/ASSAYS
Min. Order
1ASSAYS
Purity
95%~99%
Supply Ability
per week:100kg
Release date
2019-09-05

873697-71-3, OMecaMtiv MecarbilRelated Search:


  • 1-Piperazinecarboxylic acid,4-[[2-fluoro-3-[[[(6-methyl-3-pyridinyl)amino]carbonyl]amino]phenyl]methyl]-, methyl ester
  • OMecaMtiv Mecarbil
  • OMecaMtiv Mecarbil (CK-1827452)
  • CK1827452
  • CK-1827452
  • CK-1827452 (OMecaMtiv Mecarbil)
  • CK 1827452O
  • mecamtiv mecarbil
  • Methyl 4-[[2-fluoro-3-[N'-(6-methylpyridin-3-yl)ureido]phenyl]methyl]piperazine-1-carboxylate
  • methyl 4-(2-fluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate
  • Methyl 4-[[2-fluoro-3-[N'-(6-methylpyridin-3-yl)ureido]phenyl]methyl]piperazine-1-carboxylate Omecamtiv mecarbil(CK1827452)
  • methyl 4-[(2-fluoro-3-{[(6-methylpyridin-3-yl)carbamoyl]amino}phenyl)methyl] piperazine-1-carboxylate
  • OMECAMTIV MECARBIL (CK-1827452);CK1827452
  • CK 1827452 - Omecamtiv Mecarbil | CK-452
  • CK-1827452; CK1827452;CK 1827452
  • CS-827
  • CK1827452, >98%
  • Omecamtiv mecarbil?, >98%
  • OMecaMtiv Mecarbil USP/EP/BP
  • 1-Piperazinecarboxylic acid,4-[[2-fluoro-3-[[[(6-methyl-3-py...
  • 873697-71-3
  • C20H24FN5O3
  • Inhibitors